Merck & Co., Inc. and Idera Pharmaceuticals Sign Collaboration Agreement Incorporating Idera’s Toll-like Receptor Agonists in Merck’s Vaccine Programs
Merck & Co., Inc. and Idera Pharmaceuticals Sign Collaboration Agreement Incorporating Idera’s Toll-like Receptor Agonists in Merck’s Vaccine Programs
Dec 11, 2006
Click here to access PDF press release.